Presentation of Acute Myocardial Infarction Type 2 in a Patient with Septic Shock

Article Sidebar

PDF
Published: Nov 21, 2023
DOI: https://doi.org/10.47191/ijmscrs/v3-i11-53
Keywords:
Acute Myocardial Infarction, Type 2 MI, Septic Shock, Coronary Artery Disease, Inflammation, Demand Ischemia

Main Article Content

Vania Hailed Moreno Mora
Servicio de Medicina Interna, Centro Médico Nacional de Occidente, Guadalajara, Jalisco, México.
Christian Alfonso Torres Bazán
Servicio de Medicina Interna, Centro Médico Nacional de Occidente, Guadalajara, Jalisco, México.

Abstract

Acute myocardial infarction (MI) in the setting of septic shock presents a multifaceted clinical challenge. In this review, we explore the distinct presentation of type 2 MI among patients grappling with septic shock and coronary artery disease. The coexistence of these conditions poses significant risks, potentially leading to both type 1 and type 2 MIs. We delve into the pathophysiological underpinnings and the clinical implications of these subtypes of MI, emphasizing the altered hemodynamics and increased metabolic demand leading to type 2 MI. Our discussion highlights the differences in management and outcomes, underscoring the critical need for nuanced understanding in clinical practice.

Article Details

How to Cite
Vania Hailed Moreno Mora, & Christian Alfonso Torres Bazán. (2023). Presentation of Acute Myocardial Infarction Type 2 in a Patient with Septic Shock. International Journal of Medical Science and Clinical Research Studies, 3(11), 2826–2828. https://doi.org/10.47191/ijmscrs/v3-i11-53
Issue
Vol. 3 No. 11 (2023): Volume 03 Issue 11 November 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Ammann, P., Fehr, T., Minder, E., Günter, C., & Bertel, O. (2001). Elevation of troponin I in sepsis and septic shock. Intensive care medicine, 27, 965-969.

II. Putot, A., Derrida, S. B., Zeller, M., Avondo, A., Ray, P., Manckoundia, P., & Cottin, Y. (2018). Short-term prognosis of myocardial injury, type 1, and type 2 myocardial infarction in the emergency unit. The American journal of medicine, 131(10), 1209-1219.

III. Kamat, I. S., Nazir, S., Minhas, A. M. K., Nambi, V., Kulkarni, P., Musher, D., ... & Jneid, H. (2022). Outcomes of Hospitalizations With Septic Shock Complicated by Types 1 and 2 Myocardial Infarction. The American Journal of Cardiology, 174, 27-33.

IV. Jacobi, J. (2022). The pathophysiology of sepsis—2021 update: Part 1, immunology and coagulopathy leading to endothelial injury. American Journal of Health-System Pharmacy, 79(5), 329-337.

V. Nduka, O. O., & Parrillo, J. E. (2011). The pathophysiology of septic shock. Critical Care Nursing Clinics, 23(1), 41-66.

VI. Cecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018). Sepsis and septic shock. The Lancet, 392(10141), 75-87.

VII. DeFilippis, A. P., Chapman, A. R., Mills, N. L., De Lemos, J. A., Arbab-Zadeh, A., Newby, L. K., & Morrow, D. A. (2019). Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation, 140(20), 1661-1678.

VIII. Wereski, R., Kimenai, D. M., Bularga, A., Taggart, C., Lowe, D. J., Mills, N. L., & Chapman, A. R. (2022). Risk factors for type 1 and type 2 myocardial infarction. European Heart Journal, 43(2), 127-135.

IX. Basalay, M. V., Yellon, D. M., & Davidson, S. M. (2020). Targeting myocardial ischaemic injury in the absence of reperfusion. Basic Research in Cardiology, 115, 1-16.

X. Barnett, C. F., Brusca, S. B., Hanff, T. C., Blumer, V., Kalif, A., & Kanwar, M. (2023). Management of cardiogenic shock unrelated to acute myocardial infarction. Canadian Journal of Cardiology, 39(4), 406-419.